Efstathios A. Kouninis - Nov 25, 2024 Form 4 Insider Report for PEGASYSTEMS INC (PEGA)

Role
VP of Finance & CAO
Signature
/s/ Ewelina Kemp, Attorney-in-Fact for Efstathios A. Kouninis
Stock symbol
PEGA
Transactions as of
Nov 25, 2024
Transactions value $
-$88,556
Form type
4
Date filed
11/27/2024, 04:04 PM
Previous filing
Nov 13, 2024
Next filing
Dec 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PEGA Common stock Options Exercise $88.6K +1.88K $47.27 1.88K Nov 25, 2024 Direct
transaction PEGA Common stock Tax liability -$110K -1.17K -62.24% $94.50 708 Nov 25, 2024 Direct F1
transaction PEGA Common stock Sale -$66.9K -708 -100% $94.50 0 Nov 25, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEGA Stock Options Options Exercise $0 -1.88K -100% $0.00 0 Nov 25, 2024 Common stock 1.88K $47.27 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the exercise price of the stock options referenced in Table II and Mr. Kouninis's tax liability, which were paid by way of the Company withholding shares of equal value.
F2 Does not include shares of common stock subject to unvested restricted stock units and/or options awards.
F3 On March 7, 2023, the reporting person was granted an option to purchase 7,500 shares of common stock. The option vests in two installments, with up to 25% to vest on the first anniversary of the date of grant based on Pegasystems' satisfaction of certain performance criteria for the fiscal year ended December 31, 2023, and with up to 75% to vest on the second anniversary of the date of grant based on Pegasystems' satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. The performance criteria for the fiscal year ended December 31, 2023 were met in full, resulting in vesting of the option as to 1,875 shares.